Volume 6, supplement issue 1, December 2013

European comments on Medullary Thyroid Cancer Management Guidelines of the American Thyroid Association

Issue editors

Ulla Feldt-Rasmussen
Barbara Jarzab

12 articles in this issue

Introduction to European comments on “Medullary Thyroid Cancer: management guidelines of the American Thyroid Association”

Authors
- Barbara Jarzab
- Ulla Feldt-Rasmussen
- Content type: Review
- Open Access
- Published: 14 March 2013
- Article: S1
Calcitonin estimation in patients with nodular goiter and its significance for early detection of MTC: european comments to the guidelines of the American Thyroid Association

Authors
- Rossella Elisei
- Cristina Romei
- Content type: Review
- Open Access
- Published: 14 March 2013
- Article: S2
Extent of surgery in clinically evident but operable MTC – when is central and/or lateral lympadenectomy indicated?

Authors
- Oliver Gimm
- Content type: Review
- Open Access
- Published: 14 March 2013
- Article: S3
Serum calcitonin estimation in medullary thyroid cancer: basal or stimulated levels?

Authors
- Chantal Daumerie
- Dominique Maiter
- Damien Gruson
- Content type: Review
- Open Access
- Published: 14 March 2013
- Article: S4
Postoperative follow up in patients showing no evident residual disease - cut-offs for imaging/ intervention

Authors
- Michele N Minuto
- Paolo Miccoli
- Content type: Review
- Open Access
- Published: 14 March 2013
- Article: S5
Clinical comments related to medullary thyroid cancer diagnosis and management

Authors
- Leonidas H Duntas
- Content type: Review
- Open Access
- Published: 14 March 2013
- Article: S6
Treatment of advanced medullary thyroid cancer

Authors
- Johannes Smit
- Content type: Review
- Open Access
- Published: 14 March 2013
- Article: S7
The optimal range of RET mutations to be tested: European comments to the guidelines of the American Thyroid Association

Authors
- Laura Fugazzola
- Simone De Leo
- Michela Perrino
- Content type: Review
- Open Access
- Published: 14 March 2013
- Article: S8
Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers – the role of Ct serum level

Authors (first, second and last of 5)
- Barbara Jarzab
- Sylwia Szpak-Ulczok
- Jolanta Krajewska
- Content type: Review
- Open Access
- Published: 14 March 2013
- Article: S9
Management of hyperparathyroidism (PHP) in MEN2 syndromes in Europe

Authors
- Maria Alevizaki
- Content type: Review
- Open Access
- Published: 14 March 2013
- Article: S10
Presentation of points of general discussion and voting among the speakers of the European Thyroid Association-Cancer Research Network (ETA-CRN) meeting in Lisbon, 2009, entitled ”European comments to ATA medullary thyroid cancer guidelines”

Authors (first, second and last of 4)
- Barbara Jarząb
- Aleksandra Król
- Beata Jurecka-Lubieniecka
- Content type: Review
- Open Access
- Published: 14 March 2013
- Article: S11
Results and summary of voting among the audience during presentation and discussion of Medullary Thyroid Carcinoma clinical guidelines prepared by American Thyroid Association

Authors
- Ulla Feldt-Rasmussen
- Folke Soderstrom
- Content type: Review
- Open Access
- Published: 14 March 2013
- Article: S12

Volume 6, supplement issue 1, December 2013

European comments on Medullary Thyroid Cancer Management Guidelines of the American Thyroid Association

Introduction to European comments on “Medullary Thyroid Cancer: management guidelines of the American Thyroid Association”

Calcitonin estimation in patients with nodular goiter and its significance for early detection of MTC: european comments to the guidelines of the American Thyroid Association

Extent of surgery in clinically evident but operable MTC – when is central and/or lateral lympadenectomy indicated?

Serum calcitonin estimation in medullary thyroid cancer: basal or stimulated levels?

Postoperative follow up in patients showing no evident residual disease - cut-offs for imaging/ intervention

Clinical comments related to medullary thyroid cancer diagnosis and management

Treatment of advanced medullary thyroid cancer

The optimal range of RET mutations to be tested: European comments to the guidelines of the American Thyroid Association

Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers – the role of Ct serum level

Management of hyperparathyroidism (PHP) in MEN2 syndromes in Europe

Presentation of points of general discussion and voting among the speakers of the European Thyroid Association-Cancer Research Network (ETA-CRN) meeting in Lisbon, 2009, entitled ”European comments to ATA medullary thyroid cancer guidelines”

Results and summary of voting among the audience during presentation and discussion of Medullary Thyroid Carcinoma clinical guidelines prepared by American Thyroid Association

For authors

Explore

Navigation

Volume 6, supplement issue 1, December 2013

European comments on Medullary Thyroid Cancer Management Guidelines of the American Thyroid Association

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors (first, second and last of 5)

Authors

Authors (first, second and last of 4)

Authors

For authors

Explore

Search

Navigation